RIVAROXABAN 10mg. IP

A novel blood thinner that prevents the formation of blood clots in the body. (Jonathan P Piccini, 2008) Possesses a rapid onset of action than warfarin for several thromboembolic indications. (Singh & Emmady, 2021) Potentially an attractive alternative to vitamin K antagonists. (Jonathan P Piccini 1, 2008) More effectively prevents venous thromboembolism and stroke in patients with atrial fibrillation than enoxaparin. (Tyan F Thomas, 2013) An effective option for the prophylaxis of venous thromboembolism after elective total knee replacement, total hip replacement surgery. (Tyan F. Thomas, 2013) A beneficial therapeutic agent for prevention of venous thromboembolic events after major elective orthopedic surgery. (N Rosencher, 2008) A promising alternative to current pharmacological agents for thromboembolic disorders. (E Perzborn, 2007) More effective drug than subcutaneous enoxaparin in preventing postoperative venous thromboembolism in patients undergoing total hip replacement or total knee replacement surgery. (Sean T Duggan, 2009)